The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Vaccination with genetically engineered allergens prevents progression of allergic disease
Open accessAbstract
IgE-mediated allergy affects >25% of the population in industrialized countries. Repeated contact with the disease-eliciting allergens induces rises of allergen-specific IgE Abs and progression of the disease to more severe manifestations. Our study uses a type of vaccine that is based on genetically modified allergen derivatives to treat allergic patients. We developed hypoallergenic derivatives of the major birch pollen allergen, Bet v 1, by genetic engineering and vaccinated birch pollen-allergic patients ( n = 124) in a double-blind, placebo-controlled study. Active treatment induced protective IgG Abs that inhibited allergen-induced release of inflammatory mediators. We also observed a reduction of cutaneous sensitivity as well as an improvement of symptoms in actively treated patients. Most important, rises of allergen-specific IgE induced by seasonal birch pollen exposure were significantly reduced in vaccinated patients. Vaccination with genetically engineered allergen derivatives is a therapy for allergy that not only ameliorates allergic reactions but also reduces the IgE production underlying the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E.-M., Jacobson, M. R., O'Brien, F., Noble, W., Till, S. J., Hamid, Q. A., & Nouri-Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,373
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440106 · Cited by 1,368
THE HIGH-AFFINITY I g E RECEPTOR (FcεRI): From Physiology to Pathology
Kinet, J.-P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.931 · Cited by 968
The germless theory of allergic disease: revisiting the hygiene hypothesis
Wills-Karp, M., Santeliz, J., & Karp, C. L. (2001) · Nature Reviews Immunology · doi:10.1038/35095579 · Cited by 788
Breiteneder, H., Pettenburger, K., Bito, A., Valenta, R., Kraft, D., Rumpold, H., Scheiner, O., & Breitenbach, M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03597.x · Cited by 676
Self-citationVALENTA, LIDHOLM, NIEDERBERGER, HAYEK, KRAFT, & GRÖNLUND (1999) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.1999.00653.x · Cited by 531
Lichtenstein, L. M., Ishizaka, K., Norman, P. S., Sobotka, A. K., & Hill, B. M. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107204 · Cited by 342
The future of antigen-specific immunotherapy of allergy
Valenta, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri824 · Cited by 314
Self-citationAllergic rhinobronchitis: The asthma–allergic rhinitis link
Simons, F. E. R. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70320-9 · Cited by 289
Drachenberg, K. J., Wheeler, A. W., Stuebner, P., & Horak, F. (2001) · Allergy · doi:10.1034/j.1398-9995.2001.056006498.x · Cited by 285
Self-citationMothes, N., Heinzkill, M., Drachenberg, K. J., Sperr, W. R., Krauth, M. T., Majlesi, Y., Semper, H., Valent, P., Niederberger, V., Kraft, D., et al. (2003) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2003.01699.x · Cited by 269
Self-citationVrtala, S., Hirtenlehner, K., Vangelista, L., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119330 · Cited by 213
Self-citationInterleukin 3 activates human blood basophils via high-affinity binding sites.
Valent, P., Besemer, J., Muhm, M., Majdic, O., Lechner, K., & Bettelheim, P. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.14.5542 · Cited by 204
Self-citationDurham, S. R., Gould, H. J., Thienes, C. P., Jacobson, M. R., Masuyama, K., Rak, S., Lowhagen, O., Schotman, E., Cameron, L., & Hamid, Q. A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271123 · Cited by 168
Movérare, R., Elfman, L., Vesterinen, E., Metso, T., & Haahtela, T. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.13248.x · Cited by 163
Ball, T., Sperr, W. R., Valent, P., Lidholm, J., Spitzauer, S., Ebner, C., Kraft, D., & Valenta, R. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199906)29:06<2026::aid-immu2026>3.0.co;2-2 · Cited by 141
Self-citationGenetic engineering of a hypoallergenic trimer of the major birch pollen allergen, Bet v 1
Vrtala, S., Hirtenlehner, K., Susani, M., Akdiş, M., Kussebi, F., Akdiş, C. A., Blaser, K., Hufnagl, P., Binder, B. R., Politou, A. S., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0767fje · Cited by 127
Self-citationVrtala, S., Susani, M., Sperr, W. R., Valent, P., Laffer, S., Dolecek, C., Kraft, D., & Valenta, R. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80156-4 · Cited by 102
Self-citationvan Hage-Hamsten, M., Kronqvist, M., ZETTERSTRÖM, O., Johansson, E., Niederberger, V., Vrtala, S., Grönlund, H., Grönneberg, R., & Valenta, R. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70077-1 · Cited by 93
Self-citationPauli, Purohit, Oster, Frederic de, B. L. A. Y., Vrtala, S., Niederberger, V., Kraft, & Valenta (2000) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2000.00869.x · Cited by 90
Self-citationImmunotherapy of Allergic Disease
Valenta, R., Ball, T., Focke, M., Linhart, B., Mothes, N., Niederberger, V., Spitzauer, S., Swoboda, I., Vrtala, S., Westritschnig, K., et al. (2004) · Advances in immunology · doi:10.1016/s0065-2776(04)82003-0 · Cited by 89
Self-citationBall, T., Fuchs, T., Sperr, W. R., Valent, P., Vangelista, L., Kraft, D., & Valenta, R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1277 · Cited by 80
Self-citationMaximal rise in IgE antibody following ragweed pollination season
Henderson, L. L., Larson, J. B., & Gleich, G. J. (1975) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(75)80003-0 · Cited by 70
Aghayan-Ugurluoglu, R., Ball, T., Vrtala, S., Schweiger, C., Kraft, D., & Valenta, R. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2000.104782 · Cited by 55
Self-citationTransition of recombinant allergens from bench to clinical application
Cromwell, O., Suck, R., Kahlert, H., Nandy, A., Weber, B., & Fiebig, H. (2004) · Methods · doi:10.1016/j.ymeth.2003.08.009 · Cited by 47
Self-citationNasal provocation with allergen induces a secondary serum IgE antibody response
Naclerio, R. M., Adkinson, N. F., Moylan, B., Baroody, F. M., Proud, D., Kagey‐Sobotka, A., Lichtenstein, L. M., & Hamilton, R. G. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70143-x · Cited by 44
Mahler, V., Vrtala, S., Kuß, O., Diepgen, T. L., Suck, R., Cromwell, O., Fiebig, H., Hartl, A. J., Thalhamer, J., Schuler, G., et al. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01857.x · Cited by 43
Self-citationNorman, P. S., & Lichtenstein, L. M. (1978) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(78)90118-5 · Cited by 29
The Immune Response to Intrinsic and Extrinsic Allergens: Determinants of Allergic Disease
Woodfolk, J. A., & Platts‐Mills, T. A. E. (2002) · International Archives of Allergy and Immunology · doi:10.1159/000067595 · Cited by 24
Clinton, P. M., Kemeny, D. M., Youlten, L. J. F., & Lessof, M. H. (2009) · International Archives of Allergy and Applied Immunology · doi:10.1159/000234921 · Cited by 18
Cited by
Immunological mechanisms of allergen-specific immunotherapy
Larché, M., Akdis, C. A., & Valenta, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1934 · Cited by 849
Self-citationMechanisms of allergen-specific immunotherapy
Akdis, C. A., & Akdis, M. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.030 · Cited by 803
Allergen injection immunotherapy for seasonal allergic rhinitis
Calderon, M. A., Alves, B., Jacobson, M., Hurwitz, B., Sheikh, A., & Durham, S. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001936.pub2 · Cited by 678
Vaccines: past, present and future
Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 592
(2007) · doi:10.1007/978-3-540-37885-3 · Cited by 476
Metadata
- Authors
- Niederberger, V., Horak, F., Vrtala, S., Spitzauer, S., Krauth, M.-T., Valent, P., Reisinger, J., Pelzmann, M., Hayek, B., Kronqvist, M., Gafvelin, G., Grönlund, H., Purohit, A., Suck, R., Fiebig, H., Cromwell, O., Pauli, G., van Hage-Hamsten, M., & Valenta, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-10-05
- Volume
- 101
- Issue
- suppl_2
- Pages
- 14677-14682
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2159285246
- Cited by
- 376
- References
- 31
- FWCI
- 14.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.